Regional Market Expansion Leverage Shalina’s pan-African footprint and distribution strength to introduce new products and private-label opportunities across government and private healthcare channels in markets like Nigeria, DRC, Ghana and Kenya. With a diversified portfolio and sourcing from WHO-approved facilities, there are ready channels for both prescription and OTC products through established import, warehousing and last-mile logistics.

Diversified Portfolio Advantage Offer cross-sell and co-marketing opportunities using the company’s 450+ products across anti-malarials, antibiotics, anti-inflammatories and nutrition, plus its Germol consumer hygiene line and diagnostic services. This enables bundled tender proposals, hospital formulary introductions, and multi-channel campaigns across Africa and beyond.

Public Sector Fit Align with malaria control and essential medicines initiatives by partnering with national programs and government buyers. Shalina’s history of collaboration with public health authorities provides a ready pathway for competitive procurements, targeted distribution to facilities and participation in disease-control campaigns.

Consumer Division Growth Capitalize on the recent Consumer Division launch to access pharmacy chains, retailers and e-commerce across Africa and the UAE. Opportunities include private-label consumer health and hygiene products, as well as marketing collaborations around Germol and other consumer brands.

Digital and Data Enablement Leverage Shalina’s technology and analytics stack to optimize sourcing, forecasting and demand planning. Propose digital partnerships for platform integrations, API-enabled ordering, and analytics-driven marketing to accelerate product adoption and improve procurement efficiency across markets.